{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Rasteiro AM"],"funding":["Centro de Investigação do IPO-Porto","Fundação para a Ciência e Tecnologia"],"pagination":["107"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8950778"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["9(3)"],"pubmed_abstract":["Cancer of the urinary bladder is a neoplasm with considerable importance in veterinary medicine, given its high incidence in several domestic animal species and its life-threatening character. Bladder cancer in companion animals shows a complex and still poorly understood biopathology, and this lack of knowledge has limited therapeutic progress over the years. Even so, important advances concerning the identification of tumour markers with clinical applications at the diagnosis, prognosis and therapeutic levels have recently been made, for example, the identification of pathological BRAF mutations. Those advances are now facilitating the introduction of targeted therapies. The present review will address such advances, focusing on small animal oncology and providing the reader with an upda"],"journal":["Veterinary sciences"],"pubmed_title":["Molecular Markers in Urinary Bladder Cancer: Applications for Diagnosis, Prognosis and Therapy."],"pmcid":["PMC8950778"],"funding_grant_id":["UIDB/CVT/00772/2020","UIDB/00511/2020","UID/AGR/04033/2020","NORTE-01-0145-FEDER-000054","PI127-CI-IPOP-118-2019"],"pubmed_authors":["Gil da Costa RM","Oliveira PA","Rasteiro AM","Sa E Lemos E"],"additional_accession":[]},"is_claimable":false,"name":"Molecular Markers in Urinary Bladder Cancer: Applications for Diagnosis, Prognosis and Therapy.","description":"Cancer of the urinary bladder is a neoplasm with considerable importance in veterinary medicine, given its high incidence in several domestic animal species and its life-threatening character. Bladder cancer in companion animals shows a complex and still poorly understood biopathology, and this lack of knowledge has limited therapeutic progress over the years. Even so, important advances concerning the identification of tumour markers with clinical applications at the diagnosis, prognosis and therapeutic levels have recently been made, for example, the identification of pathological BRAF mutations. Those advances are now facilitating the introduction of targeted therapies. The present review will address such advances, focusing on small animal oncology and providing the reader with an upda","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Feb","modification":"2025-04-04T12:56:51.186Z","creation":"2025-04-04T12:56:51.186Z"},"accession":"S-EPMC8950778","cross_references":{"pubmed":["35324835"],"doi":["10.3390/vetsci9030107"]}}